At a glance
- Originator Nonindustrial source
- Class Antiarrhythmics
- Mechanism of Action Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arrhythmias
Most Recent Events
- 03 Sep 1997 New profile
- 03 Sep 1997 Preclinical development for Arrhythmias in USA (Unknown route)